OrganiGram Holdings Inc (OGI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OrganiGram Holdings Inc (OGI) has a cash flow conversion efficiency ratio of -0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-6.30 Million ≈ $-4.56 Million USD) by net assets (CA$371.81 Million ≈ $268.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OrganiGram Holdings Inc net asset quality index to measure how much of total assets are equity-financed.
OrganiGram Holdings Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how OrganiGram Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OrganiGram Holdings Inc (OGI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
OrganiGram Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OrganiGram Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vieworks Co. Ltd
KQ:100120
|
0.043x |
|
Heidelberg Pharma AG
F:HPHA
|
-0.299x |
|
Deoleo S.A
MC:OLE
|
-0.007x |
|
Teo Seng Capital Bhd
KLSE:7252
|
0.029x |
|
Waterco Ltd
AU:WAT
|
0.044x |
|
Syncom Formulations (India) Limited
NSE:SYNCOMF
|
0.008x |
|
Husteel
KO:005010
|
-0.039x |
|
Innate Pharma
NASDAQ:IPHA
|
1.078x |
Annual Cash Flow Conversion Efficiency for OrganiGram Holdings Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of OrganiGram Holdings Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see OGI market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | CA$349.13 Million ≈ $252.56 Million |
CA$-5.99 Million ≈ $-4.33 Million |
-0.017x | -235.58% |
| 2024-09-30 | CA$305.99 Million ≈ $221.35 Million |
CA$3.87 Million ≈ $2.80 Million |
0.013x | +109.60% |
| 2023-09-30 | CA$271.62 Million ≈ $196.49 Million |
CA$-35.80 Million ≈ $-25.89 Million |
-0.132x | -84.90% |
| 2022-09-30 | CA$508.06 Million ≈ $367.52 Million |
CA$-36.21 Million ≈ $-26.19 Million |
-0.071x | -19.62% |
| 2021-09-30 | CA$479.81 Million ≈ $347.08 Million |
CA$-28.59 Million ≈ $-20.68 Million |
-0.060x | +60.45% |
| 2020-09-30 | CA$299.53 Million ≈ $216.67 Million |
CA$-45.12 Million ≈ $-32.64 Million |
-0.151x | -40.43% |
| 2019-09-30 | CA$327.01 Million ≈ $236.55 Million |
CA$-35.08 Million ≈ $-25.38 Million |
-0.107x | -55.88% |
| 2018-09-30 | CA$184.59 Million ≈ $133.53 Million |
CA$-12.70 Million ≈ $-9.19 Million |
-0.069x | +6.49% |
| 2017-09-30 | CA$83.03 Million ≈ $60.06 Million |
CA$-6.11 Million ≈ $-4.42 Million |
-0.074x | -83.82% |
| 2016-09-30 | CA$44.26 Million ≈ $32.02 Million |
CA$-1.77 Million ≈ $-1.28 Million |
-0.040x | +88.66% |
| 2015-09-30 | CA$7.85 Million ≈ $5.68 Million |
CA$-2.77 Million ≈ $-2.01 Million |
-0.353x | -193.80% |
| 2014-09-30 | CA$24.50K ≈ $17.72K |
CA$9.22K ≈ $6.67K |
0.376x | +157.42% |
| 2013-09-30 | CA$263.80K ≈ $190.83K |
CA$-172.89K ≈ $-125.06K |
-0.655x | -93.07% |
| 2012-09-30 | CA$461.87K ≈ $334.11K |
CA$-156.78K ≈ $-113.41K |
-0.339x | -- |
About OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more